NEUROENDOCRINE TUMOR OF PANCREAS
Clinical trials for NEUROENDOCRINE TUMOR OF PANCREAS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMOR OF PANCREAS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR OF PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new 'Tumor-Seeking' radiation in early cancer trial
Disease control OngoingThis is a very early safety study to find a safe dose of a new radioactive drug, [212Pb] VMT-alpha-NET, for people with advanced neuroendocrine tumors that have stopped responding to other treatments. The main goal is to see how much radiation the kidneys can safely handle during…
Matched conditions: NEUROENDOCRINE TUMOR OF PANCREAS
Phase: EARLY_PHASE1 • Sponsor: David Bushnell • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for rare pancreatic cancer patients after first treatment fails
Disease control ENROLLING_BY_INVITATIONThis study is testing whether the drug lurbinectedin can help control high-grade pancreatic neuroendocrine tumors when standard treatments have stopped working. The trial will enroll 46 patients who have already tried other cancer therapies. Researchers will measure how well the …
Matched conditions: NEUROENDOCRINE TUMOR OF PANCREAS
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC